EVO100

DRUG2 trials

Sponsors

Evofem Inc.

Conditions

ChlamydiaChlamydia Trachomatis InfectionGonorrheaSexually Transmitted Diseases

Phase 2

Phase 2B/3 Double-blinded Placebo-controlled

CompletedNCT03107377

Evofem Inc.Chlamydia Trachomatis Infection

Start: 2017-11-03End: 2019-08-22Updated: 2020-08-12

Phase 3

Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection

CompletedNCT04553068

Evofem Inc.Chlamydia, Gonorrhea, Sexually Transmitted Diseases

Start: 2020-10-15End: 2022-07-28Updated: 2024-01-30